Abstract:Understanding the tumor microenvironment, particularly the vascular density and the availability of oxygen, is key in individualizing treatment approaches and determining their efficacy. While there are many therapies including radiotherapy that are ineffective in hypoxic tumor microenvironments, here we demonstrate the heterogeneous oxygen consumption during photodynamic therapy (PDT), a non-invasive treatment method using localized light to activate a photosensitive drug in the presence of oxygen that has shown high effectiveness in the treatment of various types of tumors, including those presented in head and neck cancer (HNC) patients. While our previous work has demonstrated that blood oxygen saturation (StO2) mapped before and after treatment with ultrasound-guided photoacoustic imaging (US-PAI) can be used as a surrogate marker for the regionalized long-term efficacy of PDT, real-time monitoring of StO2 during PDT could provide additional insights on oxygen consumption and inform dose design for on the spot treatment decisions. Specifically, in this work, we integrated the US-PAI transducer probe with PDT light delivery fibers. We tested the setup on murine tumor models intravenously injected with liposomal benzoporphyrin derivative (BPD) photosensitizer at 0.5 mg/kg dose and photodynamic illumination at 100 and 400 mW/cm2 fluence rate. As expected, we observed with our US-PAI StO2 images that the rate of oxygen utilization increases when using a high fluence rate (HFR) light dose. Particularly in the higher fluence rate group, we observed StO2 reaching a minimum mid-light dose, followed by some degree of re-oxygenation. US-PAI added the advantage of spatial information to StO2 monitoring, which allowed us to match regions of re-oxygenation during therapy to retained vascular function with immunohistochemistry. Overall, our results have demonstrated the potential of US-PAI for applications in online dosimetry for cancer therapies such as PDT, using oxygen changes to detect regionalized physiological vascular response in the tumor microenvironment.

Singlet Oxygen Luminescence Image in Blood Vessels During Vascular‐Targeted Photodynamic Therapy

Nir Area Array Ccd-Based Singlet Oxygen Luminescence Imaging for Photodynamic Therapy

Two-Dimensional Singlet Oxygen Imaging with Its Near-Infrared Luminescence During Photosensitization

Monitoring of Time-Resolved Singlet Oxygen Luminescence at 1270nm by an Optical Fiber Detection System

Monitoring dosimetric parameters for vascular-targeted photodynamic therapy

In Vivo Monitoring of Singlet Oxygen Using Delayed Chemiluminescence During Photodynamic Therapy.

Correlation of in vitro cell viability and cumulative singlet oxygen luminescence from protoporphyrin IX in mitochondria and plasma membrane

Monitoring singlet oxygen in situ with delayed chemiluminescence to deduce the effect of photodynamic therapy.

Real-time Optoacoustic Monitoring of Vascular Damage During Photodynamic Therapy Treatment of Tumor.

Microfluidic Photodynamic Therapy Based on Singlet Oxygen Fluorescence Sensing

In vivo Online label-free monitoring of heterogenous oxygen utilization during phototherapy with real-time ultrasound guided photoacoustic imaging

Ultra-high Signal-to-noise Ratio Near-Infrared Chemiluminescent Probe for in Vivo Sensing Singlet Oxygen

Pulse Laser Integrated Photodynamic Therapy and Photoacoustic Imaging

Singlet Oxygen in Photodynamic Therapy

NIR-II Ratiometric Chemiluminescent/Fluorescent Reporters for Real-Time Monitoring and Evaluating Cancer Photodynamic Therapy Efficacy.

<title>Using delayed chemiluminescence as a photodynamic therapy dose metric in vivo</title>

A Photodynamic System Based on Endogenous Bioluminescence for in Vitro Anticancer Studies

The Imaging of Singlet Oxygen in Single Cells

Monitoring perfusion and oxygen saturation in port-wine stains during vascular targeted photodynamic therapy

A Novel Theranostic Nanoprobe for in Vivo Singlet Oxygen Detection and Real-Time Dose-Effect Relationship Monitoring in Photodynamic Therapy

Organic Nanoparticles with Persistent Luminescence for in Vivo Afterglow Imaging-Guided Photodynamic Therapy